Monthly Archives: December 2015

The FAST Act streamlines the JOBS Act for Emerging Growth Companies

Posted on December 30, 2015 | Leave a comment

If you have not had time over the holidays to read Congress’ newly-minted 490 page “FAST Act” highway bill (Fixing America’s Surface Transportation Act), you may want to skip to page 472.

The FAST Act has a few added provisions pertinent to capital markets, start-ups & Emerging Growth Companies planning an IPO. These updates work on top of the JOBS Act (Jumpstart Our Business Startups).

egcsign

Currently, via the JOBS Act, an Emerging Growth Company (EGC) – defined as a company with less than $1 billion in recent annual revenues –  must publicly file its IPO registration statement not fewer than 21 days prior to the start of its deal roadshow. Under the FAST Act, this window has been reduced to 15 calendar days.

Also, the FAST Act offers companies a slight “grace period” if during the lengthy IPO review process with the SEC, the company grows and generates more than $1 billion revenue threshold. They can finish the process as an EGC.

Click here for an illustrative overview of the lengthy “back-and-forth” an IPO registration has with the SEC.

Finally, under the JOBS Act, EGCs are required to supply two years of audited financial statements within their initial confidential submissions or public filings of the S-1 registration statement. Much like “grace period” mentioned above, the FAST Act now permits companies to omit historical financial information if that information would not be required in a registration statement at the time of the deal roadshow. This simplifies the work for EGCs that would complete a fiscal year during the formal SEC review process.

The full text of the FAST Act can be found here. And I don’t know why capital markets matters are buried on page 472 in a 490 page highway / transportation bill either.

Leave a comment

Posted in Industry news, SEC Regulations

VirtualInvestorConferences.com announces 2016 dates

Posted on December 29, 2015 | Leave a comment

From its humble launch in 2010, this conference series has brought tens of thousands of individual and institutional investors directly on front of CEOs and other senior executives within public companies.

(Click here to learn more about availability and pricing. Be sure to select “Virtual Investor Conferences” from the menu.)

2016 Schedule:

  • January – No event
  • February 4, 2016: OTCQX Banks
  • March 3, 2016
  • March 17, 2016: Deutsche Bank DR Event
  • April 7, 2016
  • May 5, 2016
  • June 2, 2016
  • July 7, 2016
  • August 4, 2016
  • September 8, 2016
  • October 6, 2016
  • November 3, 2016
  • December 1, 2016

Is this the right venue for your company?  One way to answer that question is by showing the quality of questions a company receives from the attending audience – all in real time. As you’ll note below, this is a very educated and engaged interaction.

Below is an actual transcript of the questions asked. Only the names have been altered for privacy.

  • Q: Can you explain the drop off of earnings growth; what is your longer term growth rate projection.
  • Q:  Any detail on your exposure to EU debt?
  • Q: Can you please review XYZs’ historical dividend policy and the future plans / changes?
  • Q: As baby boomers age, will that negatively affect financial performance?

x

  • Q: With aging population in Japan and more pay outs as they utilize their insurance how will that affect XYZ’s future eps growth. How can you be sure that the company’s investments and current premiums will keep up with future costs?
  • Q: XYZ has historically raised its dividends yearly. Haven’t yet this year. Would continued XYZ share price weakness impact management’s decision to add to the dividends when share repurchases might be more beneficial than a dividends increase?
  • Q: Yesterday my club voted to sell all of our XYZ due to what we believed to be a lot of exposure to European debt by XYZ (30% of assets) and the possibility of that debt to be deeply discounted. Were we right in this assumption?
  • Q: Can you please speak to XYZ’s dividend history – and frequency of dividend changes up or down)
  • Q: Can you speak to current valuation of XYZ – trading at a two year low. Sell side has price targets at 2X current price.
  • Q: Can you talk about interest rate risk in the investment portfolio. For example how would a 1 percent increase in rates affect the portfolio? Also has XYZ bought any company stock in the past quarter? If so how many shares?
  • Q: Are there plans to do business in counties other than US and Japan? Thank you
  • Q: How has the MARKETING CAMPAIGN marketing campaign increase sales?
  • Q: What is the next significant catalyst for XYZ?
  • Q: On a lighter note. “The Holiday marketing campaign” is becoming a familiar presence at Christmas. I am just curious on how much overall retail revenue the marketing campaign brings in annually?
  • Q: What is XYZ’s percentage goal for PIIGs investments?
  • Q: can you explain the drop off of earnings growth in 2012; what is your longer term growth rate projection.
  • Q: Are you able to discuss the expected change in number of policies due to Fukishima (sp). Simply put are you modeling for an increase in policy growth and subsequently long-term losses for your cancer insurance products (in Japan
  • Q: What changed? Benefit/claim ratios dropped. But why? The 10-K cites favorable claim trends and new more profitable products (Child endowment WAYS DAYS) that drove the claim ratio drop. What’s driving the favorable claims trend? Is it shortened in-patient hospitalization stays? Or is it a change in underwriting policy/pricing that XYZ Japan has driven?
  • Q: Your sales agents and brokers are commish only and not salaried correct?
  • Q: I heard that Japan only covers their people with health care til they are 70. Is this true? Do Japanese people buy XYZ to cover this?
  • Q: XYZ’s general account yield will decline next year as the company de-risks the portfolio. What sort of fixed income credits is XYZ looking to invest in going forward
  • Q: (YOUR COMPETITOR) now has a sizable presence in Japan after buying ABC’s DEF unit and plans to aggressively compete in the Japanese market. It appears DEF’s franchise was damaged somewhat due to the problems connected with ABC. This will change under the (YOUR COMPETITOR) umbrella. Do you view (YOUR COMPETITOR)’s entrance in the Japan market a major threat to your Japan business? How do you plan to compete against them?
  • Q: The product mix is changing at XYZ Japan. It seems some of the faster growing products like the child endowment product is less profitable. What are the catalysts to improve your benefit ratio in Japan?
  • Q: The Japan incident does not significantly affect XYZ’s business or financials is that correct?
  • Q: What do you think the next catalyst will be for XYZ (e.g. acquisition new market new product or service etc.)?
  • Q: Does XYZ plan to expand to any other Asian country such as China?
  • Q: What has been the dividend history for XYZ – how many quarters of payments
  • Q: What is your geographic split on revenues? Does XYZ operate in any other countries beyond US and Japan?

 

Leave a comment

Posted in Virtual Investor Conferences

IPOs and Transactions: December 21 – 24 / plus 2016 EDGAR deadline calendar

Posted on December 28, 2015 | Leave a comment

There were 50 transactions filed with the SEC last week.

Congratulations to all of the corporations and law firms that selected our transactions services last week including Cancer Prevention Pharmaceuticals Inc. w/ Gracin & Marlow LLP and Zysman, Aharoni, Gayer and Sullivan & Worcester LLP, XG Technology Inc. w/ Robinson Brog Leinwand Greene Genovese & Gluck PC and Shearman & Sterling LLP and Reg A+ effective filings Hamilton National Income Trust Inc. w/ Lowenstein Sandler LLP and Hunting Dog Capital Corp with Sutherland Asbill & Brennan LLP.

700_email-banner-calendar

Law firm / advisor Registrant Symbol Form Exchange
Alston & Bird LLP RENASANT CORP RNST S-4 NASDAQ
Alston & Bird LLP RREEF PROPERTY TRUST, INC. ~ S-11 ~
Arnold & Porter LLP CAPITAL BANK FINANCIAL CORP. CBF S-4 NASDAQ
Baker Botts L.L.P. LIBERTY MEDIA CORP LMCA S-4 NASDAQ
Barton LLP SUREPURE, INC. SURP S-1 OTC Markets
Brunson Chandler & Jones, PLLC DOMINOVAS ENERGY CORP DNRG S-1 OTC Markets
Butler Snow LLP SMARTFINANCIAL INC. SMBK S-3 NASDAQ
Cleary Gottlieb Steen & Hamilton LLP TRITON INTERNATIONAL LTD ~ S-4 ~
Cooley LLP AQUINOX PHARMACEUTICALS, INC AQXP S-3 NASDAQ
Cooley LLP BIOCEPT INC BIOC S-1 NASDAQ
Cravath, Swaine & Moore LLP MARRIOTT INTERNATIONAL INC /MD/ MAR S-4 NASDAQ
Davis Wright Tremaine LLP ACUCELA INC. ~ S-3 ~
Davis Wright Tremaine LLP WILLAMETTE VALLEY VINEYARDS INC WVVI S-3 NASDAQ
Dentons US LLP GALECTIN THERAPEUTICS INC GALT S-3 NASDAQ
DLA Piper LLP LAUREATE EDUCATION, INC. ~ S-4 ~
Dorsey & Whitney LLP COMBIMATRIX CORP CBMX S-1 NASDAQ
Faegre Baker Daniels LLP FIRST INTERNET BANCORP INBK S-3 NASDAQ
Fenwick & West LLP NUTANIX, INC. ~ S-1 ~
Fig Grasslands LLC FIG PUBLISHING, INC. ~ 1-A ~
Fox Rothschild LLP BIO KEY INTERNATIONAL INC BKYI S-1 OTC Markets
Gabelli Go Anywhere Trust GABELLI GO ANYWHERE TRUST ~ N-2 ~
Gibson, Dunn & Crutcher LLP MARRIOTT INTERNATIONAL INC /MD/ MAR S-4 NASDAQ
GK Investment Holdings, LLC GK INVESTMENT HOLDINGS, LLC ~ 1-A ~
Golenbock Eiseman Assor Bell & Peskoe LLP PULSE BIOSCIENCES, INC. ~ S-1 ~
Goodwin Procter LLP ACACIA COMMUNICATIONS, INC. ~ S-1 ~
Goodwin Procter LLP ESPERION THERAPEUTICS, INC. ESPR S-3 NASDAQ
Goodwin Procter LLP PROTEOSTASIS THERAPEUTICS, INC. ~ S-1 ~
Goodwin Procter LLP TIGENIX NV ~ F-1 ~
Gracin & Marlow, LLP CANCER PREVENTION PHARMACEUTICALS, INC. ~ S-1 ~
Hamilton & Associates Law Group, P.A. FORCE PROTECTION VIDEO EQUIPMENT CORP. FPVD S-1 OTC Markets
Hamilton National Income Trust, Inc. HAMILTON NATIONAL INCOME TRUST, INC. ~ 1-A ~
Hertz Global Holdings, Inc. HERTZ RENTAL CAR HOLDING COMPANY, INC. ~ 10-12B ~
Highlands REIT, Inc. HIGHLANDS REIT, INC. ~ 10-12B ~
Hogan Lovells US LLP AMERICAN HOMES 4 RENT AMH S-4 NYSE
Hunton & Williams LLP AMERICAN HOMES 4 RENT AMH S-4 NYSE
Ignyta, Inc. IGNYTA, INC. RXDX S-3 NASDAQ
Jolie Kahn, Esq. S&W SEED CO SANW S-3 NASDAQ
K&L Gates LLP METLIFE INSURANCE CO USA ~ S-3 ~
Kramer Levin Naftalis & Frankel LLP TRINITY PLACE HOLDINGS INC. TPHS S-3 NYSE
Latham & Watkins LLP IGNYTA, INC. RXDX S-3 NASDAQ
Latham & Watkins LLP WILLIAM LYON HOMES WLH S-4 NYSE
LKP Global Law, LLP PULSE BIOSCIENCES, INC. ~ S-1 ~
Locke Lord LLP TEAM INC TISI S-4 NYSE
Lowenstein Sandler LLP HAMILTON NATIONAL INCOME TRUST, INC. ~ 1-A ~
Morris, Manning & Martin, LLP RREEF PROPERTY TRUST, INC. ~ S-11 ~
Morrison & Foerster LLP BIOCEPT INC BIOC S-1 NASDAQ
Morse, Barnes-Brown & Pendleton, PC ZOOM TELEPHONICS, INC. ZMTP S-1 OTC Markets
Northwest Law Group I-MINERALS INC IMAHF S-1 OTC Markets
Phelps Dunbar LLP RENASANT CORP RNST S-4 NASDAQ
Pillsbury Winthrop Shaw Pittman LLP RENEWABLE ENERGY GROUP, INC. REGI S-3 NASDAQ
PNK Entertainment, Inc. PNK ENTERTAINMENT, INC. ~ 10-12B ~
Proskauer Rose LLP TIGENIX NV ~ F-1 ~
Pryor Cashman LLP COMBIMATRIX CORP CBMX S-1 NASDAQ
Robinson Brog Leinwand Greene Genovese & Gluck P.C. SANUWAVE HEALTH, INC. SNWV S-1 OTC Markets
Robinson Brog Leinwand Greene Genovese & Gluck P.C. XG TECHNOLOGY, INC. XGTI S-1 NASDAQ
Ropes & Gray LLP PROTEOSTASIS THERAPEUTICS, INC. ~ S-1 ~
Shartsis Friese, LLP S&W SEED CO SANW S-3 NASDAQ
Shearman & Sterling LLP XG TECHNOLOGY, INC. XGTI S-1 NASDAQ
Skadden, Arps, Slate, Meagher & Flom LLP GABELLI GO ANYWHERE TRUST ~ N-2 ~
Skadden, Arps, Slate, Meagher & Flom LLP TRITON INTERNATIONAL LTD ~ S-4 ~
Smith, Gambrell & Russell, LLP SANUWAVE HEALTH, INC. SNWV S-1 OTC Markets
Sullivan & Cromwell LLP NEW YORK COMMUNITY BANCORP INC NYCB S-4 NYSE
Sutherland Asbill & Brennan LLP HANCOCK PARK CORPORATE INCOME, INC. ~ 10-12G ~
Sutherland Asbill & Brennan LLP HUNTING DOG CAPITAL CORP. ~ 1-A ~
Sutherland Asbill & Brennan LLP MEDLEY CAPITAL CORP MCC N-2 NYSE
Team, Inc. TEAM INC TISI S-4 NYSE
Wachtell, Lipton, Rosen & Katz CAPITAL BANK FINANCIAL CORP. CBF S-4 NASDAQ
Wachtell, Lipton, Rosen & Katz NEW YORK COMMUNITY BANCORP INC NYCB S-4 NYSE
Wachtell, Lipton, Rosen & Katz TEAM INC TISI S-4 NYSE
Wilmer Cutler Pickering Hale and Dorr LLP ACACIA COMMUNICATIONS, INC. ~ S-1 ~
Wilson Sonsini Goodrich & Rosati, P.C. NUTANIX, INC. ~ S-1 ~
Xtant Medical Holdings, Inc. XTANT MEDICAL HOLDINGS, INC. XTNT S-1 NYSE
Zysman, Aharoni, Gayer and Sullivan & Worcester LLP CANCER PREVENTION PHARMACEUTICALS, INC. ~ S-1 ~

Post IPO, thousands of organizations count on us to assure regulatory compliance and target new investors.

Click here and opt-in to receive this weekly summary via email.

Click here to review the week’s underwriters.

Leave a comment

Posted in IPO week in review

IPO Underwriters of the Week: December 21 – 24 / plus 2016 EDGAR deadline calendar

Posted on December 28, 2015 | Leave a comment

Congratulations to the corporations and underwriters that worked with our transaction services team. Whether in-house, your-house or 100% virtual… click here to discover why we are the intelligent value for both traditional and confidential IPOs.

700_email-banner-calendar

Registrant Form Type Underwriter 1 Underwriter 2 Underwriter 3 +
CANCER PREVENTION PHARMACEUTICALS, INC. S-1 Aegis Capital Corp. ~ ~
BIOCEPT INC S-1 Aspire Capital Fund, LLC ~ ~
TIGENIX NV F-1 Canaccord Genuity Inc. Nomura Securities International, Inc. KBC Securities USA, Inc. / Chardan Capital Markets, LLC
DOMINOVAS ENERGY CORP S-1 GHS Investments, LLC ~ ~
ACACIA COMMUNICATIONS, INC. S-1 Goldman, Sachs & Co. Merrill Lynch, Pierce, Fenner & Smith Inc. Deutsche Bank Securities Inc. / Needham & Company, LLC / Cowen and Company, LLC / Northland Securities, Inc.
NUTANIX, INC. S-1 Goldman, Sachs & Co. Morgan Stanley & Co. LLC J.P. Morgan Securities LLC / Credit Suisse Securities (USA) LLC / Robert W. Baird & Co. Inc. / Needham & Company, LLC / Pacific Crest Securities / Piper Jaffray & Co. / Raymond James & Associates, Inc. / Stifel, Nicolaus & Company, Inc. / William Blair & Company, L.L.C. / Oppenheimer & Co., Inc.
GK INVESTMENT HOLDINGS, LLC 1-A JCC Advisors, LLC ~ ~
COMBIMATRIX CORP S-1 Ladenburg Thalmann & Co. Inc. Aegis Capital Corp. ~
PROTEOSTASIS THERAPEUTICS, INC. S-1 Leerink Partners LLC RBC Capital Markets, LLC H.C. Wainwright & Co., LLC / Robert W. Baird & Co. Inc.
PULSE BIOSCIENCES, INC. S-1 MDB Capital Group, LLC ~ ~
METLIFE INSURANCE CO USA S-3 MetLife Investors Distribution Company ~ ~
FORCE PROTECTION VIDEO EQUIPMENT CORP. S-1 RDW Capital, LLC ~ ~
XG TECHNOLOGY, INC. S-1 Roth Capital Partners, LLC ~ ~
HUNTING DOG CAPITAL CORP. 1-A WR Hambrecht + Co, LLC ~ ~

Post IPO, thousands of organizations count on us to assure regulatory compliance and target new investors.

Have a great week.

Leave a comment

Posted in Top underwriters

SEC closed on New Year’s Day: January 1, 2016

Posted on December 24, 2015 | 1 comment

In honor of the New Year celebration, the SEC is closed on Friday, January 1, 2016.  No files can be received. 

NEWYEARS

Files submitted after 5:30 pm ET, Thursday, December 31, 2015 will receive a filing date of Monday, January 4th, 2016 and will be posted to the public on January 4th.

As with other holiday closings, the following file types will receive a Thursday, December 31, 2015 filing date if filed by 10:00 pm ET on Thursday:

  • Section 16 filings (3, 3/A, 4, 4/A, 5, 5/A)
  • Filings pursuant to Rule 462(b)

For any filing with a due date of Friday, January 1, 2016 , the SEC will move the due date to Monday, January 4th, 2016

Need help? Download our 2016 filing calendar HERE.

HAPPY NEW YEAR!

1 Comment

Posted in Uncategorized

UPDATE: 1/2 day of work for SEC on December 24th

Posted on December 23, 2015 | 2 comments

This afternoon, the SEC announced that in addition to its December 25th closure, the federal government has been granted a half-day holiday on Thursday, December 24th. The EDGAR system will not receive files after 1:30 PM ET.

inger

In addition, the Filer Support Call Center will be open from 9am to 1:30pm, rather than the usual 9am to 5:30pm operating hours. EDGAR will be operational, Monday morning, December 28, 2015.

If their last minute 1/2 day is causing you problems, call Vintage right away. 866.683.5252

HAPPY & MERRY!

2 Comments

Posted in Industry news

2016 SEC filing calendar – don’t miss a deadline or holiday closing

Posted on December 23, 2015 | Leave a comment

This is the shortest post you’ll ever read here. Click here to download our 2016 SEC filing calendar. 

ppushpin

You don’t need to log-in, but if you are so inclined, there is a sign-in to receive news and updates from us.

*Pushpin not actual size

Leave a comment

Posted in Industry news, SEC Regulations

M&A: experts’ checklist for negotiations

Posted on December 22, 2015 | Leave a comment

The M&A process provides dealmakers with several opportunities to enhance acquisition value — as well as pitfalls to destroy it. What defines good targeting, negotiating, due diligence and integrating?

M&A_BLOG_ARTweek7

Our experts identified five key lessons that acquirers should bear in mind in order to make the most of their negotiations.

ONE: Be prepared. “I’m always surprised that people don’t do much real preparation work for negotiations as they should,” says Moriarty. “They do the valuation work and things around financial projections — but they rarely consider what is actually in their counterpart’s head.”

Gemello agrees, particularly when it comes to cross-border dealmaking. “Gone are the days of the imperialistic buyer that just jams something down the throat of the seller,” he says. “I spend a lot more time with my clients getting smart about the target, about how they do business, about how they will operate and behave in the negotiation, just so we can clear out as much unnecessary noise as possible.”

TWO: Anchor away. Moriarty believes that putting the question to the other side first can give a psychological advantage when discussing terms around the table. “It’s important to make the first offer,” he says. “This is a concept called anchoring. If you make the first offer, the other side will often gravitate towards it. I’ve used it myself, and seen it used against us in negotiations. I’m surprised at how it effects people and it’s a very powerful tool.”

THREE: Friend, not foe. “M&A is inherently a social interaction,” says Gemello. “You’ve got to effectively build a bridge. As the world gets smaller, successful dealmakers have to bridge the social and cultural differences between parties, and take them into account when doing a deal.” This necessity means that meeting your counterparts in person takes on paramount importance.

“The heightened era of electronic connectivity puts a premium on face-to-face meetings. You can’t substitute for time together between principals to build relationships,” he says. “It’s the principalto- principal relationship that will carry the deal to success if it’s going to happen, and the business leaders negotiating the transaction at the highest level need to have trust between them so they can efficiently work through the deal.”

FOUR: Be upfront and honest. Facing the big tasks head on first can save you time down the line. “The biggest thing for me is pinpointing where the issues are, to the extent you can sooner rather than later, and getting those items out on the table for conversation.” If you have an opportunity to do that, you can get over the big hurdles early.” When doing this, however, it is vital that dealmakers are honest and open to compromise.

“Integrity is everything,” says Drazan. “Never say never unless you mean it.”

FIVE: Time is money. If you’re able to take your time through these processes, this can help value generation greatly. “If you have time on your side, you will benefit greatly from a valuation perspective,” says Motani. “I’ve been involved in auctions and direct sales, and while auctions can accelerate the time to closing, a direct deal usually results in a more buyer friendly purchase

Download the full interviews here.

MA_EXPERTS-Recovered

Leave a comment

Posted in M&A

IPOs and Transactions: December 14 – 18 / plus “how-to” IPO webinar

Posted on December 21, 2015 | Leave a comment

There were 54 transactions filed with the SEC last week.

Congratulations to all of the corporations and law firms that selected our transactions services last week including Cellectar Biosciences Inc. w/ Ellenoff Grossman & Schole LLP and Foley Hoag LLP, Hebron Technology Co. w/ Kaufman & Canoles, PC and Shumaker, Loop & Kendrick, LLP – and Reg A+ effective filing for Fundrise Equity REIT, LLC w/ Goodwin Procter LLP.

700_email-banner-BNA

Law firm / advisor Registrant Symbol Form Exchange
Advanced Predictive Analytics Holdings, Inc. ADVANCED PREDICTIVE ANALYTICS HOLDINGS, INC. ~ 1-A ~
Baker & Hostetler LLP ENERGY FOCUS, INC/DE EFOI S-3 NASDAQ
Baker, Donelson, Bearman, Caldwell & Berkowitz, PC FRANKLIN FINANCIAL NETWORK INC. FSB S-3 NYSE
Bass, Berry & Sims PLC GLADSTONE CAPITAL CORP GLAD N-2 NASDAQ
Boxx Corporation BOXX CORP ~ 1-A ~
Burns & Levinson LLP HARVARD APPARATUS REGENERATIVE TECHNOLOGY, INC. HART S-1 NASDAQ
Cadwalader, Wickersham & Taft LLP SEACOAST BANKING CORP OF FLORIDA SBCF S-4 NASDAQ
Cleary Gottlieb Steen & Hamilton LLP WESTERN DIGITAL CORP WDC S-4 NASDAQ
Cooley LLP CELLADON CORP CLDN S-4 NASDAQ
Cooley LLP KEMPHARM, INC KMPH S-1 NASDAQ
Cooley LLP TREVENA INC TRVN S-3 NASDAQ
Davis Polk & Wardwell LLP BATS GLOBAL MARKETS, INC. ~ S-1 ~
Davis Polk & Wardwell LLP GENERAL ELECTRIC CO GE S-4 NYSE
Davis Polk & Wardwell LLP SECUREWORKS CORP ~ S-1 ~
DLA Piper LLP ARALEZ PHARMACEUTICALS INC. ~ S-4 ~
Edmunds & Williams, P.C. BANK OF THE JAMES FINANCIAL GROUP INC BOTJ S-1 NASDAQ
Ellenoff Grossman & Schole LLP CELLECTAR BIOSCIENCES, INC. CLRB S-1 NASDAQ
Ellenoff Grossman & Schole LLP HEDGEPATH PHARMACEUTICALS, INC. HPPI S-1 OTC Markets
Ellenoff Grossman & Schole LLP QUEST PATENT RESEARCH CORP QPRC S-1 OTC Markets
Foley & Lardner LLP SUNSHINE BANCORP, INC. SBCP S-3 NASDAQ
Foley Hoag LLP CELLECTAR BIOSCIENCES, INC. CLRB S-1 NASDAQ
Gemini Fund Services, LLC VERTICAL CAPITAL INCOME FUND VCAPX N-2 NASDAQ
Gewerter & Dowling,  Attys. at Law WHISKEY ACQUISITION INC. ~ S-1 ~
Goodwin Procter LLP FUNDRISE EQUITY REIT, LLC ~ 1-A ~
Gunster, Yoakley & Stewart, PA SEACOAST BANKING CORP OF FLORIDA SBCF S-4 NASDAQ
Harter Secrest & Emery LLP COPSYNC, INC. COYN S-1 NASDAQ
Hogan Lovells US LLP DENALI HOLDING INC. ~ S-4 ~
Hogan Lovells US LLP SECUREWORKS CORP ~ S-1 ~
Hunton & Williams LLP SOUTHWESTERN ELECTRIC POWER CO ~ S-3 ~
IncSmart.biz Inc. RANCHO SANTA FE MINING, INC. ~ S-1 ~
Interlink Electronics, Inc. INTERLINK ELECTRONICS INC LINK 10-12B OTC Markets
Interval Leisure Group, Inc. INTERVAL LEISURE GROUP, INC. IILG S-4 NASDAQ
Jill Arlene Robbins, P.A. U.S. STEM CELL, INC. USRM S-1 OTC Markets
Jolie Kahn, Esq. S&W SEED CO SANW S-3 NASDAQ
Jones Day ATHERSYS, INC / NEW ATHX S-3 NASDAQ
Jones Walker LLP ORRSTOWN FINANCIAL SERVICES INC ORRF S-3 NASDAQ
Kaufman & Canoles, P.C. HEBRON TECHNOLOGY CO., LTD ~ F-1 ~
Latham & Watkins LLP AZURE POWER GLOBAL LTD ~ F-1 ~
Latham & Watkins LLP COHERUS BIOSCIENCES, INC. CHRS S-3 NASDAQ
Latham & Watkins LLP COLLEGIUM PHARMACEUTICAL, INC COLL S-1 NASDAQ
Latham & Watkins LLP VISTANA SIGNATURE EXPERIENCES, INC. ~ 10-12G ~
Levinson, Gritter & DiGiore LLP ICTV BRANDS INC. ICTV S-1 OTC Markets
Medgenics, Inc. MEDGENICS, INC. MDGN.WT S-3 NYSE
Michael W. Sanders, Attorney at Law HOUSTON AMERICAN ENERGY CORP HUSA S-3 NYSE
Mitchell Silberberg & Knupp LLP VIVEVE MEDICAL, INC. VIVMF S-1 OTC Markets
Morgan, Lewis & Bockius LLP KEMPHARM, INC KMPH S-1 NASDAQ
Norton Rose Fulbright US LLP ECLIPSE RESOURCES CORP ECR S-4 NYSE
O’Melveny & Myers LLP MICROSEMI CORP MSCC S-4 NASDAQ
Pepper Hamilton LLP COLLEGIUM PHARMACEUTICAL, INC COLL S-1 NASDAQ
Pillsbury Winthrop Shaw Pittman LLP CELLADON CORP CLDN S-4 NASDAQ
Pillsbury Winthrop Shaw Pittman LLP ISIGN SOLUTIONS INC. ISGN S-1 OTC Markets
Proskauer Rose LLP COMTECH TELECOMMUNICATIONS CORP /DE/ CMTL S-3 NASDAQ
Ropes & Gray LLP HABIT RESTAURANTS, INC. HABT S-3 NASDAQ
Shartsis Friese, LLP S&W SEED CO SANW S-3 NASDAQ
Shumaker, Loop & Kendrick, LLP HEBRON TECHNOLOGY CO., LTD ~ F-1 ~
Sichenzia Ross Friedman Ference LLP GENIUS BRANDS INTERNATIONAL, INC. GNUS S-1 OTC Markets
Sichenzia Ross Friedman Ference LLP ISIGN SOLUTIONS INC. ISGN S-1 OTC Markets
Simpson Thacher & Bartlett LLP DENALI HOLDING INC. ~ S-4 ~
Simpson Thacher & Bartlett LLP PEABODY ENERGY CORP BTU S-3 NYSE
Skadden, Arps, Slate, Meagher & Flom LLP AZURE POWER GLOBAL LTD ~ F-1 ~
Skadden, Arps, Slate, Meagher & Flom LLP BATS GLOBAL MARKETS, INC. ~ S-1 ~
Skadden, Arps, Slate, Meagher & Flom LLP DENALI HOLDING INC. ~ S-4 ~
Skadden, Arps, Slate, Meagher & Flom LLP MICROSEMI CORP MSCC S-4 NASDAQ
Skadden, Arps, Slate, Meagher & Flom LLP WESTERN DIGITAL CORP WDC S-4 NASDAQ
Sutherland Asbill & Brennan LLP NEW MOUNTAIN FINANCE CORP NMFC N-2 NYSE
Thompson Hine LLP VERTICAL CAPITAL INCOME FUND VCAPX N-2 NASDAQ
Versum Materials, LLC VERSUM MATERIALS, LLC ~ 10-12B ~
Vinson & Elkins L.L.P. ANTERO RESOURCES CORP AR S-4 NYSE
Vinson & Elkins L.L.P. BOARDWALK PIPELINES LP ~ S-3 ~
Weil, Gotshal & Manges LLP GENERAL ELECTRIC CO GE S-4 NYSE
Weil, Gotshal & Manges LLP INTERVAL LEISURE GROUP, INC. IILG S-4 NASDAQ
Womble Carlyle Sandridge & Rice, LLP GEOVAX LABS, INC. GOVX S-1 OTC Markets

Post IPO, thousands of organizations count on us to assure regulatory compliance and target new investors.

Click here and opt-in to receive this weekly summary via email.

Click here to review the week’s underwriters.

Have a great week.

Leave a comment

Posted in IPO week in review

IPO Underwriters of the Week: December 14 – 18 / plus “how-to” IPO webinar

Posted on December 21, 2015 | Leave a comment

Congratulations to the corporations and underwriters that worked with our transaction services team. Whether in-house, your-house or 100% virtual… click here to discover why we are the intelligent value for both traditional and confidential IPOs.

700_email-banner-BNA

Registrant Form Underwriter 1 Underwriter 2 Underwriter 3 +
ATHERSYS, INC / NEW S-3 Aspire Capital Fund, LLC ~ ~
HARVARD APPARATUS REGENERATIVE TECHNOLOGY, INC. S-1 Aspire Capital Fund, LLC ~ ~
AZURE POWER GLOBAL LTD F-1 Barclays Capital Inc. ~ ~
KEMPHARM, INC S-1 Cowen and Company, LLC RBC Capital Markets, LLC Canaccord Genuity Inc. / Oppenheimer & Co. Inc.
COLLEGIUM PHARMACEUTICAL, INC S-1 Jefferies LLC Piper Jaffray & Co. William Blair & Company, L.L.C. / Needham & Company, LLC / Janney Montgomery Scott LLC
ISIGN SOLUTIONS INC. S-1 Joseph Gunnar & Co., LLC ~ ~
CELLECTAR BIOSCIENCES, INC. S-1 Ladenburg Thalmann & Co. Inc. ~ ~
U.S. STEM CELL, INC. S-1 Magna Equities II, LLC ~ ~
WESTERN DIGITAL CORP S-4 Merrill Lynch, Pierce, Fenner & Smith Inc. ~ ~
SECUREWORKS CORP S-1 Merrill Lynch, Pierce, Fenner & Smith Inc. Morgan Stanley & Co. LLC Goldman, Sachs & Co. / J.P. Morgan Securities LLC / Barclays Capital Inc. / Citigroup Global Markets Inc. / Credit Suisse Securities (USA) LLC / RBC Capital Markets, LLC / UBS Securities LLC / Pacific Crest Securities / Stifel, Nicolaus & Company, Inc. / SunTrust Robinson Humphrey, Inc. / William Blair & Company, L.L.C
BATS GLOBAL MARKETS, INC. S-1 Morgan Stanley & Co. LLC Citigroup Global Markets Inc. Merrill Lynch, Pierce, Fenner & Smith Inc. / Credit Suisse Securities (USA) LLC / Goldman, Sachs & Co. / J.P. Morgan Securities LLC / Jefferies LLC / Barclays Capital Inc. / Nomura Securities International Inc. / Sandler O’Neill & Partners, L.P.
VERTICAL CAPITAL INCOME FUND N-2 Northern Lights Distributors, LLC ~ ~
HEBRON TECHNOLOGY CO., LTD F-1 QMIS Finance Group ~ ~

Post IPO, thousands of organizations count on us to assure regulatory compliance and target new investors.

Have a great week.

Leave a comment

Posted in Top underwriters